Detectable safety gestalt of rheumatoid arthritis treatments from pivotal clinical drug trials

Victoria Konzett, Andreas Kerschbaumer, Laurenz Willmann, Daniel Aletaha

Open source

DOI
10.1093/rheumatology/keag263
Published
2026-06-26
Container
Rheumatology
Publisher
Oxford University Press (OUP)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/rheumatology/keag263,
  title = {Detectable safety gestalt of rheumatoid arthritis treatments from pivotal clinical drug trials},
  author = {Victoria Konzett and Andreas Kerschbaumer and Laurenz Willmann and Daniel Aletaha},
  year = {2026},
  journal = {Rheumatology},
  doi = {10.1093/rheumatology/keag263},
  url = {https://doi.org/10.1093/rheumatology/keag263}
}

RIS

TY  - JOUR
TI  - Detectable safety gestalt of rheumatoid arthritis treatments from pivotal clinical drug trials
AU  - Victoria Konzett
AU  - Andreas Kerschbaumer
AU  - Laurenz Willmann
AU  - Daniel Aletaha
PY  - 2026
JO  - Rheumatology
DO  - 10.1093/rheumatology/keag263
UR  - https://doi.org/10.1093/rheumatology/keag263
ER  - 

APA

Konzett, V., Kerschbaumer, A., Willmann, L., & Aletaha, D. (2026). Detectable safety gestalt of rheumatoid arthritis treatments from pivotal clinical drug trials. Rheumatology. https://doi.org/10.1093/rheumatology/keag263

Source records